Profil
Gérard Moxon is the Managing Director of Technomark Group Ltd and a financier by background and training.
After degrees from Durham University and the London School of Economics, he joined Lloyds Bank International and served in Brazil, France and Portugal in a number of executive positions.
On returning to the UK in 1990, he joined Lloyds Private Banking, the elite private banking group of the Lloyds Bank Group.
In 1993 Mr Moxon joined Merrill Lynch in London as Vice-President and built up a team from nothing to more than $400 million under management from a number of high net worth individuals and institutions.
On leaving Merrill Lynch in 2002 Gérard Moxon served as an executive director of Stanford International Bank of Texas and London & Capital Asset Management before purchasing the majority shareholding in Technomark with Mark Horrocks in 2005.
Ehemalige bekannte Positionen von Gérard Moxon
| Unternehmen | Position | Ende |
|---|---|---|
Technomark Investment Management Ltd.
 Technomark Investment Management Ltd. Investment ManagersFinance Technomark Investment Management Ltd. (TIM) is inactive since 2009. Formerly known as Technomark Medical Ventures, TIM is the venture capital arm and a subsidiary of Technomark Consulting Services Ltd., a consulting firm specialized in the pharmaceutical and biotechnology sectors, and the European branch of the US-based Technomark Group USA LLC, headquartered in Research Triangle Park, North Carolina. The group has additional offices in Mumbai, India and in Nanjing, China. The activities of the Technomark group include corporate finance, venture capital and management consulting focused on outsourcing in the pharmaceutical domain. Their clients are large pharmaceutical corporations, contract research organizations, contract manufacturing organizations, investment banks and public entities. Technomark's European branch operates since 1987 in London. TIM originated in 2000 with the backing of Lloyds TSB Development Capital Ltd., the venture capital arm of Lloyds TSB Group plc (LSE: LLOY; NYSE: LYG). The current firm was formally established in 2005 when the group was reorganized. TIM manages a private equity fund focused on the life sciences. | Präsident | 01.10.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance Technomark Investment Management Ltd. (TIM) is inactive since 2009. Formerly known as Technomark Medical Ventures, TIM is the venture capital arm and a subsidiary of Technomark Consulting Services Ltd., a consulting firm specialized in the pharmaceutical and biotechnology sectors, and the European branch of the US-based Technomark Group USA LLC, headquartered in Research Triangle Park, North Carolina. The group has additional offices in Mumbai, India and in Nanjing, China. The activities of the Technomark group include corporate finance, venture capital and management consulting focused on outsourcing in the pharmaceutical domain. Their clients are large pharmaceutical corporations, contract research organizations, contract manufacturing organizations, investment banks and public entities. Technomark's European branch operates since 1987 in London. TIM originated in 2000 with the backing of Lloyds TSB Development Capital Ltd., the venture capital arm of Lloyds TSB Group plc (LSE: LLOY; NYSE: LYG). The current firm was formally established in 2005 when the group was reorganized. TIM manages a private equity fund focused on the life sciences. | Finance |
